Fed. Circ. Considers Some Testing For Avadel Sleep Drug

Judges on the Federal Circuit seemed open to modifying a district court's injunction barring specialty drugmaker Avadel Pharmaceuticals from marketing its on-market narcolepsy drug for use in treating another sleep disorder...

Already a subscriber? Click here to view full article